Sanger-based direct sequencing achieves the highest specificity (100%) and can detect all sequence mutations in BRAF exons 11 and 15 (pros), but it presents the lowest diagnostic sensitivity (80–85%)—which requires a higher tumor cell representation into the tissue sample—and it is somehow time-consuming (cons). This evidence concerns the gene BRAF and neoplasm.